PROTARA THERAPEUTIC INC (TARA)
US74365U1079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.42M | -65.95M | -47.25M | -33.98M | -14.99M | |||
| Depreciation Amortization | 341.00K | 250.00K | 120.00K | 100.00K | 280.00K | |||
| Change In Working Capital | -4.14M | 540.00K | -520.00K | 630.00K | -1.89M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 30.00K | N/A | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | 6.66M | 38.71M | 13.15M | 9.84M | 960.00K | |||
| OPERATING CASH FLOW | -37.56M | -26.46M | -34.50M | -23.41M | -15.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -45.00K | -120.00K | -600.00K | -880.00K | -20.00K | |||
| Other Investing Activity | 53.15M | 15.07M | -97.60M | 3.72M | 2.50M | |||
| INVESTING CASH FLOW | 53.11M | 14.95M | -98.19M | 2.84M | 2.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -1.67M | N/A | |||
| Stock Issued/Repurchased | -91.00K | -90.00K | -230.00K | 191.07M | 0.00 | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -91.00K | -90.00K | -230.00K | 189.40M | 0.00 | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 15.46M | -11.60M | -132.92M | 168.83M | -13.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.56M | -26.46M | -34.50M | -23.41M | -15.65M | |||
| Capital Expenditure | -45.00K | -120.00K | -600.00K | -880.00K | -20.00K | |||
| FREE CASH FLOW | -37.60M | -26.58M | -35.10M | -24.29M | -15.67M | |||
All data in USD